Cancer 1 Reviewer
Cancer 1 Reviewer
CYTOPLASM VACUOLES
o Structure - The jelly-like substance composed of o Vacuoles are fluid filled organelles enclosed by a
mainly water and found between the cell membrane membrane. They can store materials such as food,
and nucleus. The cytoplasm makes up most of the water, sugar, minerals and waste products.
"body" of a cell and is constantly streaming.
o Function - Organelles are found here and DIVISION
substances like salts may be dissolved in the → The division of a cell to produce two daughter cells
cytoplasm. is fundamental to most forms of life.
→ The ‘life cycle’ of a dividing eukaryotic non-
NUCLEUS embryonic cell starts with the cell triggered to enter
o Structure - The largest organelle in the cell. It is the cell cycle and ends with the equal partitioning of
dark and round, and is surrounded by a double the genetic material and cleavage of the cell during
membrane called the nuclear envelope/membrane. cytokinesis (the physical process of cell division,
In spots the nuclear envelope fuses to form pores which divides the cytoplasm of a parental cell into
which are selectively permeable. The nucleus two daughter cells).
contains genetic information (DNA) on special → The whole process is called the cell cycle and
strands called chromosomes. consists of four main phases.
o Function - The nucleus is the "control center" of the
cell, for cell metabolism and reproduction. (G1) First Growth Phase
- Growth and normal metabolic roles
The following organelles are found (2) Synthesis Phase
in both plant and animal cells: - DNA Replication
"ER" OR ENDOPLASMIC RETICULUM (G2) Second Growth Phase
o The Endoplasmic Reticulum is a network of - Growth and preparation for mitosis
membranous canals filled with fluid. They carry (M) Mitotic Phase
materials throughout the cell. The ER is the - Prophase, Metaphase, Anaphase, Telophase
"transport system" of the cell.
o There are two types of ER: rough ER and smooth G1, S, G2 = Interphase
ER.
MITOTIC CELL DIVISION APOPTOSIS
PROPHASE → ancient Greek = “falling off”
→ cell prepares itself for the division → programmed cell death
→ average adult loses = 50-70 billion cells/day
→ average child (8-14y/o) loses = 20-30 billion
cells/day
METAPHASE
→ The disappearance of nuclear membrane and
nucleolus marks the beginning of metaphase. The
chromosomes become shorter by further coiling.
CELLULAR ABERRATIONS
→ a large group of diseases that are characterized by
uncontrolled growth and spread of an abnormal cell
→ a malignant tumor of any type
CYTOKINESIS
→ After karyokinesis NORMAL CELL CANCER CELL
(nuclear division), the have limited cell division cell division is rapid
cytoplasm is divided by undergo apoptosis; show partial or complete
the formation of the cell specific morphology differentiated function of
wall between the two parent cell is lost
daughter nuclei. This have a small nuclear- there is a large nucleus-
division of the cytoplasm cytoplasmic ratio cytoplasm ratio
is called as the
are no migratory/ cells can migrate
cytokinesis.
non-migratory
NORMAL CELL CANCER CELL 5) The Tissue Organization Field Theory (TOFT)
adhere tightly together loosely adherent - carcinogenesis is a problem of tissue
organization, comparable to organogenesis
grow in an orderly and growth rate is not during early development, and proliferation is the
well-regulated manner well-regulated default state of all cells.
cells recognize or respect do not recognize or
tissue barrier respect tissue barrier GENETICS AND CANCER
cells are contact inhibited are not contact inhibited • CARCINOGEN – any substance, situation or
exposure that can damage genetic material (DNA)
• ONCOGENE – genetic material that carries the
ability to induce cancer
• PROTO-ONCOGENE – normal gene that has the
potential to transform itself into an oncogene
• TUMOR SUPRESSOR GENE – are a family of
normal genes that instruct cells to produce proteins
that restrain cell growth and division
• P53 GENE – family of suppressor gene that triggers
apoptosis
• DNA REPAIR GENE – a code for proteins whose
normal function is to correct errors that arise when
cells duplicate their DNA prior to cell division
NODES
Nx Regional lymph nodes cannot be
assessed
N0 No regional lymph node metastasis
N1, N2, N3, N4 Increasing involvement of regional
lymph nodes
METASTASIS
Mx Distant metastasis cannot be assessed
M0 No distant metastasis
M1, M2, M3, Ascending degree of distant
metastasis, including metastasis to
distant lymph nodes
TYPES OF RADIATION
External Radiation
Teletherapy - the use of radioactive material for
production of an external beam of gamma rays for
COLORECTAL treatment at a distance from the radioactive source
• FOBT (Fecal Occult Blood Test) >50 yo (tele, meaning “at a distance”).
• Sigmoidoscopy - q5 years before age 50
• Contrast Barium Enema - q5 years after age 50 Internal Radiation
• Colonoscopy - q10 yrs after age 50 Brachytherapy - a type of internal radiation therapy in
which seeds, ribbons, or capsules that contain a
PROSTATE radiation source are placed in your body, in or near the
• DRE (Digital Rectal Exam) and PSA (Prostate tumor; treats only a specific part of your body.
Specific Antigen test) -starting age 50
Types of Internal Radiation
TERTIARY PREVENTION Unsealed (Oral, IV), Sealed
Primary Strategies, Health Counselling ,
Chemoprevention Safety Precautions For Brachytherapy
Private room, Radiation Safety Notice, Dosimeter
TREATMENT GOAL Badge, No children/pregnant visitors, No pregnant
CURE staff, STD
Complete eradication of malignant disease
CONTROL Preparations For Intracavitary Brachytherapy
Prolong survival and containment of cancer cell growth Bed rest and log roll, Indwelling urinary catheter, Low
PALLIATION residue diet, Antidiarrheal
Relief of symptoms association with the disease
IMPLANTS
FACTORS AFFECTING TREATMENT DECISIONS 1. Permanent 2. Temporary Implants (1-3 days)
Tumor cell kinetics, Tumor locations, Physical status of
the patient, Quality of life. KEY COMPONENTS OF RADIATION SAFETY
SHIELD, TIME, DISTANCE
TYPES OF SURGERY
Diagnostic, Primary Treatment, Prophylactic, Palliative,
Reconstructive
PREOPERATIVE MANAGEMENT
• Nutritional status
• Talk about concerns and ask questions
• Preoperative education: information about the
surgical procedure
“Minimize the time of exposure, maximize the distance
POST-OPERATIVE MANAGEMENT away from the sources, and maximize the shielding
between the sources and the point of exposure”
• Frequent pain assessment
• Monitor for possible
SIDE EFFECTS OF RADIATION
• Complications Localized Effect, Skin Reaction, Alopecia,
• Position changes and exercise Myelosuppression, N & V, Fatigue, Malaise
• Institute good nutrition, Asepsis, and frequent
wound assessment Patient Education To Minimize Skin Reactions
(External Radiation)
1) Clean skin gently w/ mild soap.
2) Avoid very hot water bath. Classifications of Chemo Therapeutic Agent
3) Avoid sun exposure and extremes hot or cold. (By Chemical Group)
4) Avoid rubbing/ friction (belts, buckles, straps) 1. Alkylating Agents
5) Moisturize prophylactically. 2. Nitrosoureas
6) Do not remove radiation markings. 3. Antimetabolites
4. Antitumor antibiotics
A DISLODGED RADIATION SOURCE 5. Mitotic Spindle Poisons
1. Do not touch a dislodged radiation source with bare 6. Hormones
hands. 7. Miscellaneous Agents
2. Use long-handled forceps to place the source in the
lead container kept in the client's room and call the ALKYLATING AGENTS
physician. Action: Alkylates DNA
3. If unable to locate radiation source, bar visitors and prevents DNA from being separated for synthesis or
notify the physician. transcription.
• Bone marrow depression with leukopenia and
REMOVAL OF SEALED RADIATION SOURCES thrombocytopenia
1. The client is no longer radioactive. • GIT disturbances
2. Resume sexual intercourse after 7-10 days (if • Depress of gametogenesis (mainly in men),
implants is cervical or vaginal) leading to sterility
3. Povidone-iodine douche (cervical) • Alopecia and cystitis
4. Fleet enema if prescribed. Note: Chloramphenicol decreases the metabolism of
Cyclophospamide
CHEMOTHERAPY
Factors Affecting Treatment Decisions: Bendamustine, Busulfan, Carmustine, Chlorambucil,
Tumor cell kinetics, Physical status of the patient, Chlormethine, Cyclophosphamide, Dacarbazine,
Tumor locations, Quality of life. Fotemustine, Ifosfamide, Lomustine, Melphalan,
Streptozotocin, Temozolomide
Role of Chemotherapy In The Treatment of Cancer
• ADJUVANT - Treatment that is given in addition to NITROSOUREAS
the primary (initial) treatment can cross the blood-brain barrier and are used to treat
• NEOADJUVANT - Treatment given as a first step brain tumors.
to shrink a tumor before the main treatment
• PALLIATION - is designed to relieve symptoms, Carmustine, Chlorozotocin, Cthylnitrosourea,
and improve your quality of life. Fotemustine, Lomustine, Nimustine, Ranimustine,
Semustine, Streptozocin
GOALS OF CHEMOTHERAPY
Cure, Control, Palliation CONTRAINDICATIONS OF CHEMOTHERAPY
1. Infection
CHEMO DRUGS CLASSIFICATION 2. Recent Surgery
1. Vesicants - result in tissue necrosis or formation of 3. Impaired Renal or Hepatic Function
blisters when accidentally infused into tissue 4. Recent Radiation Therapy
surrounding a vein. 5. Pregnancy
2. Exfoliants - can cause inflammation and shedding 6. Bone Marrow Depression
of skin without causing underlying tissue death
3. Irritants - can cause inflammation, pain or irritation VASCULAR ACCESS DEVICE
at the extravasation site, without any blister (VADs) are inserted into veins via peripheral or central
formation vessels for diagnostic or therapeutic reasons, such as
4. Inflammitants - cause mild to moderate blood sampling, central venous pressure readings,
inflammation, painless skin erythema and elevation administration of medication, fluids, total parenteral
at the extravasation site nutrition (TPN) and blood transfusions.
5. Neutrals - neither cause inflammation nor damage
upon extravasation PERIPHERALLY-INSERTED CENTRAL CATHETERS
(PICC) is a form of vascular access that is inserted at a
Routes of Cytotoxic Drug Administration peripheral site such as the veins of the arms and
Oral, Subcutaneous, Intramuscular, Intrathecal, extends in the central venous system at the superior
Intravenous vena cava.